Category: Pim Kinase

ELISA testing (for lower avidity anti-dsDNA antibodies) accompanied by risk stratification by using more stringent assays (Farr, EliA,Crithidia) and restricting the relevance of anti-dsDNA antibody existence to particular clinical manifestations may provide us with an improved index from the pathogenicity of anti-dsDNA antibodies

ELISA testing (for lower avidity anti-dsDNA antibodies) accompanied by risk stratification by using more stringent assays (Farr, EliA,Crithidia) and restricting…